In vivo antitumor activity of novel water-soluble taxoids

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1155-1158

  Mikuni, Katsuhiko ^a   Nakanishi, Katsuyoshi ^a   Hara, Koji ^a   Hara, Kozo ^a   Iwatani, Wakao ^b   Amano, Tetsuya ^b   Nakamura, Kosho ^b   Tsuchiya, Yoshinori ^b   Okumoto, Hiroshi ^c   Mandai, Tadakatsu ^c  

^a Ensuiko Sugar Refining Co Ltd   (Japan)

^b KAKEN PHARMACEUTICAL CO LTD   (Japan)

^c KURASHIKI UNIVERSITY OF SCIENCE AND THE ARTS   (Japan)

Author keywords

Antitumor; Derivative; Docetaxel; Paclitaxel; Prodrug

Indexed keywords

DOCETAXEL; GALACTOSE; GLUCOSE; MANNOSE; PACLITAXEL; PACLITAXEL DERIVATIVE; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; IN VIVO STUDY; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; SERUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BODY WEIGHT; CHEMISTRY, PHYSICAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDICATORS AND REAGENTS; LEUKEMIA P388; MALE; MICE; SOLUBILITY; TAXOIDS; WATER;

EID: 45749107880     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1155     Document Type: Article

References (16)

1. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T., J. Am. Chem. Soc., 93, 2325-2327 (1971).
2. Greenwald R. B., Pendri A., Bolikal D., Gilbert C. W., Bioorg. Med. Chem. Lett., 4, 2465-2470 (1994).
3. Greenwald R. B., Gilbert C. W., Pendri A., Conover C. D., Xia J., Martinez A., J. Med. Chem., 39, 424-431 (1996).
4. Li C., Yu D., Inoue T., Yang D. J., Milas L., Hunter N. R., Kim E. E., Wallace S., Anticancer Drugs, 7, 642-648 (1996).
5. Paradis R., Page M., Anticancer Res., 18, 2711-2716 (1998).
6. Vyas D. M., Wong H., Crosswell A. R., Casazza A. M., Knipe J. O., Mamber S. W., Doyle T. W., Bioorg. Med. Chem. Lett., 3, 1357-1360 (1993).
7. Ueda Y., Mikkilineni A. B., Knipe J. O., Rose W. C., Casazza A. M., Vyas D. M., Bioorg. Med. Chem. Lett., 3, 1761-1766 (1993).
8. Golik J., Wong H. S. L., Chen S. H., Doyle T. W., Wright J. J. K., Knipe J., Rose W. C., Cassaza A. M., Vyas D. M., Bioorg. Med. Chem. Lett., 6, 1837-1842 (1996).
9. Damen E. W., Wiegerinck P. H. G., Braamer L., Sperling D., de Vos D., Scheeren H. W., Bioorg. Med. Chem. Lett., 8, 427-432 (2000).
10. de Bont D. B. A., Leenders R. G. G., Haisma H. J., van der Meulen-Muileman I., Scheeren H. W., Bioorg. Med. Chem., 5, 405-414 (1997).
11. Paradis R., Page M., Int. J. Oncol., 12, 391-394 (1998).
12. Lataste H., Senilh V., Wright M., Guenard D., Potier P., Proc. Natl. Acad. Sci. U.S.A., 81, 4090-4094 (1984).
13. Senilh V., Blechert S., Colin M., Guenard D., Picot F., Potier P., Varenne P., J. Nat. Prod., 47, 131-137 (1984).
14. Mandai T., Okumoto H., Oshitari T., Nakanishi K., Mikuni K., Hara K., Hara K., Heterocycles, 52, 129-132 (2000).
15. Mandai T., Okumoto H., Oshitari T., Nakanishi K., Mikuni K., Hara K., Hara K., Iwatani W., Amano T., Nakamura K., Tsuchiya Y., Heterocycles, 54, 561-566 (2001).
16. Bissery M.-C., Nohynek G., Sanderink G.-J., Lavelle F., Anticancer Drugs, 6, 339-355 (1995).